通过表面介导的自发乳化,以乙化为媒介,为半类胺
Qi Li1, Vasudev Tangry1, David P Allen2
1Department of Chemical and Biomolecular Engineering, Center for Neutron Science, University of Delaware, Newark, DE 19716.
概括
像西马格卢提德 (semaglutide) 这样的乙基化可以形成不稳定的合体,称为ouzo形成,特别是在疏水表面附近. 这项研究阐明了这种物理不稳定的机制,有助于药物配方.
科学领域:
- 物理化学 物理化学
- 体科学 体科学 体科学
- 制药配方 制药配方 制药配方
背景情况:
- 乙基化,如葡萄糖类-1受体激动剂,是2型糖尿病和肥胖症的关键治疗方法.
- 这些治疗药物表现出物理不稳定性,特别是自发乳化 (ouzo形成),当暴露在疏水表面时.
研究的目的:
- 在不同的溶液条件下,描述塞马格卢提德体相的物理性质.
- 阐明表面催化合体形成背后的机制及其对表面特性的依赖.
主要方法:
- 利用光散射,小角度X射线散射和圆形二元化来分析合相性质.
- 采用经典雷利模型来预测合体形成和大小.
- 模拟的合物形成率作为自催化反应和与汉森溶解度参数相关的表面可湿性.
主要成果:
- 通过雷利模型成功预测了semaglutide合体的存在和大小.
- 证明疏水表面催化合物形成,自催化反应后的速度.
- 建立了表面湿透性,汉森溶解性参数和合物形成率之间的相关性.
结论:
- 提供了关于在乙烯酸中形成乌佐的不寻常的体现象的见解.
- 确定控制合体大小和形成的关键参数,以表面特性为指导.
- 提供了在制药行业优化合成和药物产品配方的指导.
更多相关视频
06:34Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
Published on: November 29, 2024
238
10:58SNARE-mediated Fusion of Single Proteoliposomes with Tethered Supported Bilayers in a Microfluidic Flow Cell Monitored by Polarized TIRF Microscopy
Published on: August 24, 2016
10.9K
相关概念视频
Glucagon-like Receptor Agonists
325
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
325
Lipid Digestion
91.8K
Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
91.8K
Insulin Secretory Vesicles
5.0K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.0K
